Brain Conflux (ISSN: 3079-6016) is committed to promoting the publication of high-quality academic research. Manuscripts that present experimental data will qualify for a waiver of the article processing charges (APCs).

Overview

Brief introduction

Brain Conflux (ISSN: 3079-6016) is an open-access and Life Conflux Press partner journal launched by scientists. The journal aims to promote neuroscience and medicine by publishing original researches, reproducible methods or protocols, and systematic reviews. The goal is to publish highly impactful papers with a wide range of readers, and to provide peers with novel findings, easy-to-use analysis tools, and systematic knowledge.

With a focus on the latest research spanning molecular mechanisms, cellular biology, neural networks, and clinical applications, Brain Conflux will provide a platform for cutting-edge scientific discoveries that push the boundaries of what we know about the brain. Our aim is to foster interdisciplinary collaboration across disciplines and geographical boundaries, creating a forum where researchers, clinicians, and policy-makers can exchange ideas and advance the understanding of neurological diseases. The journal will focus on a broad array of topics—from the genetic and epigenetic factors that influence brain development and disease, to the latest advancements in neuroimaging and biomarker discovery, to innovative therapeutic strategies that could one day offer hope to millions.

Through Brain Conflux, we hope to foster a vibrant and thriving community of scientists who are passionate about transforming brain science into tangible healthcare solutions. Whether you are working on uncovering the cellular mechanisms that contribute to neurodegenerative diseases, exploring the genetic underpinnings of psychiatric disorders, or developing novel therapeutic interventions, Brain Conflux provides a platform for you to share your groundbreaking work with the world. Our journal will publish original research, reviews, clinical studies, and insights into the practical applications of neuroscience, encouraging research that bridges the gap between bench and bedside.

But we are not just focused on the science. We are also deeply committed to promoting the impact of neuroscience on public health and policy. The challenges posed by neurological diseases are not just scientific—they are societal. The need for effective treatments is matched by the urgent need for healthcare systems to adapt to the growing burden of brain disorders. Through Brain Conflux, we aim to facilitate discussions that will shape the policies, clinical practices, and research priorities that can better support the global effort to combat neurological diseases. We encourage researchers and clinicians to submit work that not only advances the scientific understanding of the brain, but also addresses the practical needs of patients and healthcare systems around the world.

As we launch Brain Conflux, we are not just beginning a new journal—we are embarking on a new era of brain science. The winds of progress are strong, and the future of neuroscience is brighter than ever. With rapid advancements in technology—such as neuroimaging, genetic sequencing, and stem cell research—we are closer than ever to unlocking the mysteries of the brain. This progress is exhilarating, as each new discovery brings us one step closer to new treatments, new cures, and new ways of improving the lives of people affected by neurological diseases. The possibilities for the future are boundless, and Brain Conflux will be the platform where these discoveries come to life.

The journey ahead is one of exploration, collaboration, and discovery. We stand on the precipice of a transformative era in brain science, and we invite you to be part of this exciting adventure. The scientific community has a unique opportunity to make lasting contributions to the treatment and prevention of neurological diseases. By working together across disciplines and borders, we can push the boundaries of what is possible and ultimately improve the lives of millions around the world.

The future is now, and the future of brain science is full of promise. With Brain Conflux, we are creating a space where the most innovative ideas can come together, and where breakthroughs will fuel the next generation of neuroscience. We invite researchers, clinicians, and policymakers to join us on this extraordinary journey. Together, we can unlock the mysteries of the brain and make a lasting impact on the future of healthcare. The winds of progress are here, and the time to act is now. Let us set sail into this new era of discovery and innovation, charting a course toward a future where the mysteries of the brain are no longer unknown, but understood, and where solutions to neurological diseases are within reach. The journey has begun—let’s ride the waves of discovery and shape the future of neuroscience together.

Unique Features

• Video submission: 3~5 min speech video to introduce your work
• Reproducible: analysis method with video tutorial
• Figure polishing: to ensure highest quality output
• Promotion by social media: WeChat, and Weibo with 500,000 followers in bioinformatics
• Open access: golden open access and 4500 USD / 3807 GBP / 4496 EUR APC waiver before 2026
• Publishing is the beginning: news promotion, translated version, and method updates (protocols, software, database, or scripts)

Scope

The Brain Conflux is an open-access and Life Conflux Press partner journal launched by scientists. The journal aims to promote neuroscience and medicine by publishing original researches, reproducible methods or protocols, and systematic reviews. The goal is to publish highly impactful papers with a wide range of readers, and to provide peers with novel findings, easy-to-use analysis tools, and systematic knowledge.

• Clinical Neurology
• Neuroimaging
• Neurobiology
• Neurosurgery
• Psychiatry
• Pediatric Neurology
• Artificial Intelligence in Neuroscience
• Bioinformatics
• Epidemiology
• Geriatrics
• Neuro-oncology

Future Indexing Information

• Biological Abstracts (Clarivate Analytics)
• BIOSIS (Clarivate Analytics)
• CAS: Chemical Abstracts Service (ACS)
• Current Contents: Life Sciences (Clarivate Analytics)
• Directory of Open Access Journals (DOAJ)
• PubMed (NLM)
• Science Citation Index Expanded (Clarivate Analytics)
• SCOPUS (Elsevier)
• Web of Science (Clarivate Analytics)

Brain Conflux (ISSN: 3079-6016) will deposit all articles in PMC (PubMed Central)